Viking Therapeutics, Inc. (VKTX) Discusses Top Line Data from VK2735 Maintenance Study in Obesity and Type 2 Diabetes - Slideshow (NASDAQ:VKTX) 2026-09-22

核心观点 - 文档内容为技术性错误提示,要求启用Javascript和cookies,并禁用广告拦截器以继续访问[1] 技术访问限制 - 浏览器需启用Javascript和cookies功能[1] - 广告拦截器可能导致访问被阻止,需禁用后刷新页面[1]

Viking Therapeutics, Inc. (VKTX) Discusses Top Line Data from VK2735 Maintenance Study in Obesity and Type 2 Diabetes - Slideshow (NASDAQ:VKTX) 2026-09-22 - Reportify